Genpact (G) shares surged 5.10% in pre-market trading on Friday, following a series of positive developments that have bolstered investor confidence in the company's future prospects. The stock's upward movement comes on the heels of raised price targets from analysts and the company's announcement of ambitious medium-term growth targets.
TD Cowen has shown increased optimism for Genpact by raising its price target to $55 from $53, while reiterating a Buy rating on the stock. This sentiment was echoed by Jefferies analyst Surinder Thind, who also maintained a Buy rating with a price target of $52. These positive analyst actions reflect growing confidence in Genpact's business model and future performance.
Adding to the bullish sentiment, Genpact unveiled its medium-term targets during an investor day presentation. The company aims to achieve at least 7% revenue growth and double-digit adjusted earnings growth in the coming years. This forward-looking guidance has resonated well with investors, contributing to the stock's pre-market rally as market participants adjust their expectations for Genpact's future financial performance.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。